Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Aimmune Therapeutics, Inc. (AIMT)
|
Add to portfolio |
|
|
|
| Price: |
$34.35
| | Metrics |
| OS: |
65.5
|
M
| |
-160
|
% ROE
|
| Market cap: |
$2.25
|
B
| |
-411
|
% ROIC
|
|
Net cash:
|
$187
|
M
| |
$2.85
|
per share
|
|
EV:
|
$2.06
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($278)
|
M
| |
|
|
|
EBIT
|
($283)
|
M
| |
|
|
| EPS |
($4.50)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 124.0 | 133.4 | 89.3 | 54.6 | 19.8 | 8.2 | 3.5 |
| General and administrative | 125.8 | 81.9 | 43.9 | 26.9 | 16.2 | 3.0 | 1.3 |
| EBIT | -249.8 | -215.3 | -133.3 | -81.5 | -36.0 | -11.1 | -4.8 |
| Pre-tax income | -247.8 | -210.7 | -131.3 | -80.8 | -35.8 | -11.1 | -4.8 |
| Income taxes | 0.7 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -248.5 | -210.8 | -131.3 | -80.8 | -35.8 | -11.1 | -4.8 |
| |
| Diluted EPS | ($3.97) | ($3.67) | ($2.61) | ($1.89) | ($1.88) | ($3.80) | ($1.65) |
| Shares outstanding (diluted) | 62.6 | 57.4 | 50.4 | 42.8 | 19.0 | 2.9 | 2.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|